An interventional study of Smartphone Based Alcohol Monitoring (SAM) and Tracking and Reducing Alcohol Consumption (TRAC) in Risk Behavior, Alcohol Use Disorder and HIV Infections, sponsored by University of Kentucky. Recruiting at 2 sites in United States. Open to participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-03-30.
Sponsored by University of Kentucky · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 84 studies in Risk-Taking with a site in United States — 9 open to participants now, 11 under way, none of them phase 3. Risk-Taking · United States.
Among the 84 studies in Risk-Taking with a site in United States, this one is the 25th largest by planned enrollment of the 77 interventional ones that give a count, is one of 6 that started in 2024, is one of 60 with no phase, reaches primary completion later than 3 of the 10 other live ones, and was the 75th registered.
136 studies on the registry are indexed under Risk-Taking; 18 are open to participants now.
Browse Risk-Taking studies →9 of the 84 studies in Risk-Taking with a site in United States are open now. Recruiting first, the newest first:
Ohio State University Comprehensive Cancer Center · Sites in United States
Ages 18–25 · Women only · Healthy volunteers
Yale University · Sites in United States
Ages 18+ · Women only · Healthy volunteers
VA Office of Research and Development · Sites in United States
Ages 22–65
Ohio State University · Sites in United States
Ages 14–24
Ohio State University Comprehensive Cancer Center · Sites in United States
Ages 18–65 · Healthy volunteers
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 15 Risk-Taking studies recruiting now, 4 (27%) set no upper age limit and 11 (73%) stop at 75 or younger; 8 take children under 18; 9 take healthy volunteers.
This study: 18 Years to 35 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
84 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 9 · Phase 2 7 · Phase 3 3 · Phase 4 2
First in 2000; this study’s year is marked. 6 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 405 is above the median of 255 across 117 interventional studies indexed under Risk-Taking.
Median enrollment 237 across the 77 interventional studies, 120 across the 7 observational. Of the 69 that completed or were terminated, 19 (28%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 84 has an industry lead sponsor. The 10 most frequent:
University of Kentucky is the lead sponsor of 68 studies on the registry; 7 are open to participants now.
University of Kentucky has 1 study filed under Risk-Taking — fewer than ten, so there is no comparison to draw.
4 of the studies in Risk-Taking with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06684613Yale UniversityIntegrating PrEP Decision Making Into Counseling in Sexual and Reproductive Health Clinics | 2027-03-01 |
| NCT05576350University of KentuckyTRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk | 2027-05 |
| NCT07320664Ohio State University Comprehensive Cancer CenterBreast Cancer Study Tracking Risk Awareness of Alcohol Consumption and Improving Knowledge in Young Adult Women | 2027-07-01 |
| NCT04110756University of California, San FranciscoChangeGradients: Promoting Adolescent Health Behavior Change | 2027-07-31 |
Add all 4 to your calendar (.ics) → With an account.
Among the 84 studies in Risk-Taking with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Ecological momentary interventions (EMI), which use phones to deliver messages to reduce alcohol use and related risk behaviors during or prior to drinking events, can help to address triggers in real-time. GPS tracking can determine when individuals visit places they have previously reported drinking or triggers to drink and then EMI messages can be delivered upon arrival to prevent risky alcohol use. A mobile app has been developed that uses GPS tracking to determine when individuals visit "risky" places and then delivers a survey asking what behaviors they engaged in while at the location.
The goal of the proposed study is to use this app to enhance the Tracking and Reducing Alcohol Consumption (TRAC) intervention by delivering messages that encourage participants to employ strategies discussed during TRAC sessions when arriving at risky places. When they leave these places, they will complete a survey and breathalyzer reading in order to collect event-level self-report and biological data on alcohol use and HIV risk. If their breathalyzer result indicates alcohol use, they will receive harm reduction messaging. It is expected that combining TRAC with EMI ("TRAC-ER") will increase effectiveness by reinforcing topics discussed during these sessions, providing in-the-moment messaging to address triggers, and collecting real-time alcohol use data.
For this study, the investigators will enhance an existing mHealth intervention (TRAC) to reduce alcohol use among young adults at risk for HIV by combining the intervention with an app which delivers EMI messages in real-time. Upon enrollment, participants will be randomized into one of 3 arms: TRAC-ER (EMI messaging, TRAC intervention, and smartphone-based alcohol monitoring), TRAC (TRAC intervention and smartphone-based alcohol monitoring), or a comparison group (smartphone-based alcohol monitoring only).
Participants will be recruited from Kentucky and Connecticut through community-based recruitment and health clinics.
Preliminary data used for this study were collected from a study (PI: Lauckner, K01AA02530) testing the TRAC intervention with people living with HIV/AIDS, which has shown promising preliminary results, with high feasibility, acceptability, and encouraging preliminary outcomes.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
HIV
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants in this group will engage only in smartphone-based alcohol monitoring.
Behavioral: Smartphone Based Alcohol Monitoring (SAM)
Participants in this group will receive the Tracking and Reducing Alcohol Consumption (TRAC) intervention and smartphone-based alcohol monitoring.
Behavioral: Smartphone Based Alcohol Monitoring (SAM) · Behavioral: Tracking and Reducing Alcohol Consumption (TRAC)
Participants in this group will receive the Tracking and Reducing Alcohol Consumption (TRAC) intervention combined with GPS-based ecological momentary interventions (EMI) and smartphone-based alcohol monitoring.
Behavioral: Smartphone Based Alcohol Monitoring (SAM) · Behavioral: Tracking and Reducing Alcohol Consumption (TRAC) · Behavioral: TRAC-ER
Smartphone-based alcohol monitoring (SAM) using mobile breathalyzers and surveys.
The TRAC intervention focuses on increasing motivation and building skills for avoiding triggers and managing situations that encourage drinking. It requires four 30-minute sessions with a counselor using videoconferencing and mobile phones. In addition to receiving the four sessions of intervention content, participants will complete smartphone-based self-monitoring of alcohol consumption, which will be discussed during intervention sessions.
Ecological momentary interventions (EMI) use phones to deliver messages to reduce alcohol use and related risk behaviors during or prior to drinking events. GPS tracking can determine when individuals visit places they have previously reported drinking or triggers to drink and then EMI messages can be delivered upon arrival to prevent risky alcohol use.
Number of drinking days
Number of days in which alcohol was consumed based on breathalyzer readings greater than 0.00
Time frame: Measured daily for 30 day periods during months 1, 2, 3, 6, and 9
Number of binge drinking episodes
Number of binge drinking episodes (occasions when participants had 5+ drinks based on self-reported number of drinks)
Time frame: Measured daily for 30 day periods during months 1, 2, 3, 6, and 9
Number of drinks/drinking day
3 items: alcohol consumed (yes or no), number of drinks, and time spent drinking
Time frame: Measured daily for 30 day periods during months 1, 2, 3, 6, and 9
Plan to share: No
No publications or documents are linked to this record.
Started Dec 2024 (actual). Primary completion is estimated for May 2027, 29 months after the start.
Of 65 non-industry interventional studies with no phase under Risk-Taking, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 48. This study's planned 29 months is close to that.
Counting every sponsor, half of 68 studies reached it within 28 months; a quarter within 7 and three quarters within 49.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Kentucky